The Versartis biotech pharmaceutical company in San Diego has just announced that they are developing a long-acting growth hormone peptide that will be used to treat Type II Diabetes.
Preclinical data has proved its efficacy.
But, their studies will not start until the second quarter of 2010.
They expect it will take at least two years to get the product to market (and possibly longer).
Are diabetes sufferers willing to wait that long? Remember, Diabetes takes an extreme toll on your body.
Meanwhile, our patients have been introduced to testosterone and human growth hormone peptides for over 10 years, and have experienced improved insulin resistance, along with positive body composition changes and weight loss.
Weight loss alone often corrects Type II Diabetes.
Most people do not know that Type II diabetes is often caused by changes in hormone levels The combination of testosterone replacement, along with a new peptide GHRP-6 which has been developed to instigate the release of one's own human growth hormone, combined with a healthy low-glycemic index diet, easily reverses Type II Diabetes.
The new peptide is GHRP-6 and is available by prescription through certified compounding pharmacies.
It functions as a Human Growth Hormone releaser within the human body.
One of the features of the integrative medicine and interventional endocrinology we practice at Doctor's Age Management is that we understand the importance of taking a look at your full body chemistry and lifestyle to address health problems.
This is a better overall program than simply prescribing medications to mask the symptoms of the true problem.